Addus HomeCare Analyst Ratings
Oppenheimer Maintains Outperform on Addus HomeCare, Raises Price Target to $130
Pediatrix Medical Group Analyst Ratings
Deutsche Bank Upgrades Pediatrix Medical Group to Hold From Sell, $8 Price Target
Wolfe Research Adjusts Price Target on HCA Healthcare to $358 From $357
Jefferies Raises HCA Healthcare's Price Target to $390 From $350
Encompass Health Analyst Ratings
Stephens & Co. Reiterates Overweight on Encompass Health, Maintains $94 Price Target
Morgan Stanley Adjusts COMPASS Pathways Price Target to $23 From $30, Maintains Overweight Rating
Buy Rating Affirmed for Imac Holdings Amidst Strategic Transformation and Strong Q1 Performance
iMac Holdings Inc: Ascendiant Capital Markets Raises Price Target from $8 to $8.25
Stephens & Co. : The Addus HomeCare (ADUS.US) rating was maintained, and the target price was adjusted from $120.00 to $128.00.
Addus HomeCare Analyst Ratings
Goldman Sachs Adjusts Price Target on HCA Healthcare to $340 From $311
Goldman Sachs Adjusts Price Target on Universal Health Services to $200 From $189
Truist Financial Sticks to Their Buy Rating for Biote (BTMD)
RBC Capital Keeps Their Buy Rating on The Ensign Group (ENSG)
Addus Homecare Corp: Stephens raised price target from $120 to $128
Universal Health Servs Analyst Ratings
Komo: Maintaining the Universal Health Servs (UHS.US) rating, adjusted from neutral to neutral, and adjusted the target price from $182.00 to $186.00.